Why Coherus Biosciences Inc (NASDAQ:CHRS) Stock declined -14.89% in Last Three Months?
Robert W. Baird raised the price target for the Coherus Biosciences Inc (NASDAQ:CHRS) stock to “an Outperform”. The rating was released on November 17, 2023, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $12. The stock was initiated by Truist, who disclosed in […]
A leader in the success game: Coherus Biosciences Inc (CHRS) Stock
Robert W. Baird raised the price target for the Coherus Biosciences Inc (NASDAQ:CHRS) stock to “an Outperform”. The rating was released on November 17, 2023, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $12. The stock was initiated by Truist, who disclosed in […]
Coherus Biosciences Inc (NASDAQ:CHRS) stock Posted Gross Margin of 36.43 percent in Last Year: Is Justifiable?
Robert W. Baird raised the price target for the Coherus Biosciences Inc (NASDAQ:CHRS) stock to “an Outperform”. The rating was released on November 17, 2023, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $12. The stock was initiated by Truist, who disclosed in […]
Why Coherus Biosciences Inc (NASDAQ:CHRS) Stock fell -39.80% in Last Six Months?
Robert W. Baird raised the price target for the Coherus Biosciences Inc (NASDAQ:CHRS) stock to “an Outperform”. The rating was released on November 17, 2023, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $12. The stock was initiated by Truist, who disclosed in […]
Does Coherus Biosciences Inc (CHRS) Stock have plenty of room for growth?
Robert W. Baird raised the price target for the Coherus Biosciences Inc (NASDAQ:CHRS) stock to “an Outperform”. The rating was released on November 17, 2023, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $12. The stock was initiated by Truist, who disclosed in […]
Coherus Biosciences Inc (CHRS) Stock Is Emerging from the Clouds
Robert W. Baird raised the price target for the Coherus Biosciences Inc (NASDAQ:CHRS) stock to “an Outperform”. The rating was released on November 17, 2023, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $12. The stock was initiated by Truist, who disclosed in […]
Analysts Estimated Revenue of $91.52M in the current quarter for Coherus Biosciences Inc (NASDAQ:CHRS) Stock
Robert W. Baird raised the price target for the Coherus Biosciences Inc (NASDAQ:CHRS) stock to “an Outperform”. The rating was released on November 17, 2023, according to finviz. The research report from Citigroup has initiated the stock to Buy, with a price target set at $12. The stock was initiated by Truist, who disclosed in […]
